Unfortunately, compared with YM-01, which inhibited tumor growth of xenograft models of breast and melanoma, YM-08 had a reduced anti-tau activity and cytotoxicity in cancer cells [112,113]. The gene discussed is MAPT; the disease is neoplasm.